ClinicalTrials.gov
ClinicalTrials.gov Menu

Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 Diabetes (PROCEED)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01393808
Recruitment Status : Completed
First Posted : July 13, 2011
Last Update Posted : March 3, 2017
Sponsor:
Collaborator:
Abbott
Information provided by (Responsible Party):
Mario Negri Institute for Pharmacological Research